Depression is major mental health cause of Global Burden of disease. Its consequences further lead to significant burden to public health, which include higher risk of dementia, premature mortality arising from physical disorders and maternal depression impacts on child growth and development.[43] Approximately 76% to 85% of depressed people in low and middle income countries are not receiving treatments;[44] barriers to treatment include: inaccurate assessment, lack of trained health care providers, social stigma and lack of resources.[45] The World Health Organization constructed guidelines aiming to increase services for people with mental, neurological and substance use disorders known as The Mental Health Gap Action Programme (mhGAP).[45] Depression is listed as one of conditions prioritized by the programme. Trials conducted show possibilities for the programme to be implemented on low-resource primary care settings dependent on primary care practitioners and lay health workers.[46] Examples of therapies by the mhGAP targeting depression are the Group Interpersonal Therapy as group treatment for depression and Thinking Health which utilizes cognitive behavioral therapy to tackle perinatal depression.[45] Furthermore, effective screening in primary care is crucial for the access of treatments. The mhGAP programme adopted its approach of improving detection rate of depression by training general practitioners. However, there is still weak evidence supporting this training.[43]